Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.12−0.02 (-1.75%)
Close on Nov 13, 2026Market cap $195.18MP/E –Yield –
Palisade Bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Palisade Bio's profit margin for the twelve months ending Sep 30, 2026 was -8739.2%. For fiscal 2023 it was -4920.0%, against -76346.2% the year before. The highest annual figure on record is -1894.1% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -4920.0% | +71426.2 |
| FY2020 | Dec 31, 2020 | -76346.2% | −22093.5 |
| FY2019 | Dec 31, 2019 | -54252.6% | −52358.6 |
| FY2018 | Dec 31, 2018 | -1894.1% | +4131.3 |
| FY2017 | Dec 31, 2017 | -6025.4% | +123696.5 |
| FY2016 | Dec 31, 2016 | -129721.8% | +70949.2 |
| FY2015 | Dec 31, 2015 | -200671.0% | −80516.3 |
| FY2014 | Dec 31, 2014 | -120154.7% | −102125.8 |
| FY2013 | Dec 31, 2013 | -18029.0% | −15546.4 |
| FY2012 | Dec 31, 2012 | -2482.5% | +722.2 |
| FY2011 | Dec 31, 2011 | -3204.7% | −697.7 |
| FY2010 | Dec 31, 2010 | -2507.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2114.8% | +71925.2 |
| Q1 FY2023 | Mar 31, 2023 | -936.0% | +38665.3 |
| Q4 FY2020 | Dec 31, 2020 | -169760.0% | −88255.8 |
| Q3 FY2020 | Sep 30, 2020 | -73720.0% | −3194.6 |
| Q2 FY2020 | Jun 30, 2020 | -74040.0% | −55837.3 |
| Q1 FY2020 | Mar 31, 2020 | -39601.3% | +84958.4 |
| Q4 FY2019 | Dec 31, 2019 | -81504.2% | −68691.4 |
| Q3 FY2019 | Sep 30, 2019 | -70525.4% | +2686.0 |
| Q2 FY2019 | Jun 30, 2019 | -18202.7% | −17954.4 |
| Q1 FY2019 | Mar 31, 2019 | -124559.7% | −38681.0 |
| Q4 FY2018 | Dec 31, 2018 | -12812.8% | −11499.6 |
| Q3 FY2018 | Sep 30, 2018 | -73211.3% | −67860.0 |
| Q2 FY2018 | Jun 30, 2018 | -248.3% | +185719.3 |
| Q1 FY2018 | Mar 31, 2018 | -85878.7% | +216811.4 |
| Q4 FY2017 | Dec 31, 2017 | -1313.2% | +60384.0 |
| Q3 FY2017 | Sep 30, 2017 | -5351.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -185967.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -302690.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -61697.2% | – |
See a number that looks wrong?